Business Description
Valbiotis SA
ISIN : FR0013254851
Total Employee Number:
50Compare
Compare
Traded in other countries / regions
ALVAL.France8JD.Germany IPO Date
2021-02-15Description
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.71 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | -0.57 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.03 | |||||
Beneish M-Score | 4.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16 | |||||
3-Year EBITDA Growth Rate | 25.7 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 23.8 | |||||
3-Year Book Growth Rate | -35 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 202.85 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.52 | |||||
9-Day RSI | 37.08 | |||||
14-Day RSI | 37.73 | |||||
3-1 Month Momentum % | 8.63 | |||||
6-1 Month Momentum % | 68.65 | |||||
12-1 Month Momentum % | 46.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.85 | |||||
Quick Ratio | 2.26 | |||||
Cash Ratio | 2.07 | |||||
Days Inventory | 386.95 | |||||
Days Sales Outstanding | 42.75 | |||||
Days Payable | 188.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.7 | |||||
Shareholder Yield % | -17.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -146.19 | |||||
Operating Margin % | -1049.17 | |||||
Net Margin % | -1040.55 | |||||
EBITDA Margin % | -989.61 | |||||
FCF Margin % | -904.86 | |||||
OCF Margin % | -888.18 | |||||
ROE % | -97.15 | |||||
ROA % | -52.43 | |||||
ROIC % | -199.45 | |||||
3-Year ROIIC % | -51.32 | |||||
ROC (Joel Greenblatt) % | -460.7 | |||||
ROCE % | -71.1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 17.8 | |||||
PB Ratio | 2.77 | |||||
Price-to-Tangible-Book | 3.37 | |||||
EV-to-EBIT | -2.65 | |||||
EV-to-EBITDA | -2.73 | |||||
EV-to-Revenue | 27.03 | |||||
EV-to-FCF | -3.05 | |||||
Price-to-GF-Value | 0.55 | |||||
| Price-to-Net-Current-Asset-Value | 4.31 | |||||
| Price-to-Net-Cash | 15.5 | |||||
Earnings Yield (Greenblatt) % | -37.79 | |||||
FCF Yield % | -29.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valbiotis SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.905 | ||
| EPS (TTM) (€) | -0.486 | ||
| Beta | 1.0359 | ||
| 3-Year Sharpe Ratio | -0.32 | ||
| 3-Year Sortino Ratio | -0.41 | ||
| Volatility % | 68.32 | ||
| 14-Day RSI | 37.73 | ||
| 14-Day ATR (€) | 0.031358 | ||
| 20-Day SMA (€) | 0.85322 | ||
| 12-1 Month Momentum % | 46.56 | ||
| 52-Week Range (€) | 0.521844 - 1.27342 | ||
| Shares Outstanding (Mil) | 35.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valbiotis SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valbiotis SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valbiotis SA Frequently Asked Questions
What is Valbiotis SA(FRA:8JD)'s stock price today?
The current price of FRA:8JD is €0.78. The 52 week high of FRA:8JD is €1.27 and 52 week low is €0.52.
When is next earnings date of Valbiotis SA(FRA:8JD)?
The next earnings date of Valbiotis SA(FRA:8JD) is .
Does Valbiotis SA(FRA:8JD) pay dividends? If so, how much?
Valbiotis SA(FRA:8JD) does not pay dividend.
Press Release
Articles on Valbiotis SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers